|
⚲
|
| Keyboard |
| Binder-Scholl Gwendolyn Knowlton
✚
|
|
|---|---|
| CIK # | 0001662116 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001662116] | |
| 4 | [0001662116] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Binder-Scholl Gwendolyn Knowlton | |
| Adaptimmune Therapeutics PLC |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Adaptimmune Therapeutics PLC ADAP
American Depositary Shares representing Ordinary Shares
|
2019-01-14 | Sell | 1,514 | $5.37 | 8,130 |
|
Adaptimmune Therapeutics PLC ADAP
American Depositary Shares
|
2018-10-01 | Sell | 25,000 | $13.79 | 344,750 |
|
Adaptimmune Therapeutics PLC ADAP
American Depositary Shares
|
2018-08-29 | Sell | 25,000 | $10.25 | 256,250 |
|
Adaptimmune Therapeutics PLC ADAP
Option to purchase Ordinary Shares · derivative
|
2018-01-12 | Grant | 429,984 | $0.00 | |
|
Adaptimmune Therapeutics PLC ADAP
Option to purchase Ordinary Shares · derivative
|
2018-01-12 | Grant | 96,036 | $0.00 | |
|
Adaptimmune Therapeutics PLC ADAP
Option to purchase Ordinary Shares · derivative
|
2017-01-13 | Grant | 2,072,976 | $0.00 | |
|
Adaptimmune Therapeutics PLC ADAP
Option to purchase Ordinary Shares · derivative
|
2016-01-18 | Grant | 704,961 | $0.00 |